文献速递甲状腺与颈部外科

无促结缔组织增生的包裹性单灶散发性甲状腺髓样癌可放弃淋巴结清扫

Abandoning node dissection for desmoplasia-negative encapsulated unifocal sporadic medullary thyroid cancer.
PubMed 文献 · Surgery · 2021-10-01

该研究对139例≤25 mm的单灶散发性甲状腺髓样癌患者进行组织病理学分层,评估促结缔组织增生和肿瘤包膜完整性对淋巴结转移的术中预测价值。结果显示无促结缔组织增生且包膜完整的患者中,分别有57%和48%的淋巴结清扫被回顾性认为不必要。结论认为在专科中心此类患者可放弃淋巴结清扫。

要点

  • 促结缔组织增生程度增加和包膜完整性下降与淋巴结转移显著相关(P < .001)。
  • 无促结缔组织增生且包膜完整的患者淋巴结清扫不必要比例分别为57%和48%。
  • 冰冻切片与石蜡切片诊断一致率为98%(53/54对)。

核心结论

  • 无促结缔组织增生的包裹性单灶散发性甲状腺髓样癌患者可能在专科中心放弃淋巴结清扫。

研究设计与样本

  • 对139例≤25 mm的单灶散发性甲状腺髓样癌患者进行组织病理学分层研究,评估促结缔组织增生(7级递增)和肿瘤包膜完整性(5级递减)对淋巴结转移的术中预测价值。

主要发现

  • 促结缔组织增生增加和包膜完整性下降与淋巴结病变显著相关(P < .001),淋巴结病变率从0分别升至79%和62%。
  • 淋巴结转移数量中位数从0分别升至3和2个,生化治愈率从100%分别降至36%和58%。
  • 促结缔组织增生(低-中度至高度,纤维化>10%)和包膜突破(>3处延伸;1处延伸宽度>3 mm;或无包膜弥漫生长)的敏感性和阴性预测值均为100%,特异性分别为57%和48%,阳性预测值分别为50%和46%。
  • 回顾性分析中,无促结缔组织增生和包裹性肿瘤患者分别有55例(57%)和47例(48%)的淋巴结清扫不必要。
  • 冰冻切片与石蜡切片组织病理学比较一致率为98%(53/54对),1/7升级改变诊断为促结缔组织增生,1/3降级将包膜突破诊断从「存在」改为「缺失」。

关键数值与推荐

  • 促结缔组织增生分级:7级递增;包膜完整性分级:5级递减。
  • 促结缔组织增生高度定义为纤维化>10%。
  • 包膜突破定义为>3处延伸、1处延伸宽度>3 mm或无包膜弥漫生长。

临床怎么用

  • 在专科中心,对无促结缔组织增生且包膜完整的单灶散发性甲状腺髓样癌(≤25 mm)患者,可考虑放弃淋巴结清扫。
  • 术中冰冻切片可用于评估促结缔组织增生和包膜完整性,与石蜡切片一致率高。

局限性

  • 回顾性分析,淋巴结清扫必要性为回顾性判断。
  • 冰冻切片与石蜡切片比较的样本量有限(54对)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Predictive criteria to determine the absence of node metastases from thyroid specimens are scarce for sporadic medullary thyroid cancer. METHODS: Histopathologic stratification of patients with unifocal sporadic medullary thyroid cancer ≤25 mm with ≥10 neck nodes at thyroidectomy to evaluate the suitability of desmoplasia (7 increments) and tumor capsule integrity (5 decrements) for intraoperative prediction of node metastasis in unifocal sporadic medullary thyroid cancer. RESULTS: Paraffin-embedded thyroid specimens were available for 139 eligible patients. Significant (P < .001) associations were found between increasing desmoplasia and decreasing tumor capsule integrity and nodal disease (from 0 to 79% and 0 to 62%); the number of node metastases (medians, from 0 to 3 and 0 to 2 nodes); and biochemical cure (from 100 to 36% and 100 to 58%). Desmoplasia (low-moderate to high, with fibrosis >10%) and breach of the tumor capsule (>3 extensions; 1 extension >3 mm in width; or diffuse growth without tumor capsule) yielded excellent sensitivity and negative predictive value (100%), with moderate specificity (57 and 48%) and positive predictive value (50 and 46%). In retrospect, node dissection proved unnecessary in 55 (57%) and 47 (48%) patients who harbored desmoplasia-negative and encapsulated tumors. When available frozen sections were histopathologically compared with matching paraffin-embedded thyroid tumor specimens, concordance was 98% (53 of 54 pairs): 1 of 7 upgrades changed the diagnosis to desmoplasia, whereas 1 of 3 downgrades shifted the diagnosis of tumor capsule breach from "present" to "absent." CONCLUSIONS: Patients with desmoplasia-negative encapsulated sporadic medullary thyroid cancer may forgo node dissection at specialist centers.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Machens A, Kaatzsch P, Lorenz K, et al. Abandoning node dissection for desmoplasia-negative encapsulated unifocal sporadic medullary thyroid cancer. Surgery. 2021. PMID: 34602296. doi:10.1016/j.surg.2021.07.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。